Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-08-27
DOI
https://doi.org/10.3324/haematol.2026.301363
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines

Shefali Mehra, Andrew Lane, Shai Shimony, Justin Taylor et al.
Haematologica
Lung Cancer Treatments and Mutations
article

Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines

Shefali Mehra, Andrew Lane, Shai Shimony, Justin Taylor, Erica N. Lamkin
article en

Abstract

No abstract available for this paper.
Haematologica
University of Miami (US), Dana-Farber Cancer Institute (US), Sylvester Comprehensive Cancer Center (US)
Florida Department of Health, Edward P. Evans Foundation, Sylvester Comprehensive Cancer Center, University of Miami Health Systems, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences
Openalex Percentile: Top 11%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.